Percutaneous tumor ablation with radiofrequency.

Area of Science:

• Oncology
• Minimally Invasive Surgery
• Medical Technology

Background:

• Radiofrequency thermal ablation (RFA) is an emerging minimally invasive treatment for localized cancer.
• Minimally invasive options offer advantages in resources, time, recovery, cost, morbidity, and mortality compared to traditional methods.
• Image-guided local treatments must demonstrate efficacy comparable to more invasive procedures.

Purpose of the Study:

• To review the current status of image-guided tumor ablation therapy.
• To highlight the need for further scientific evaluation of RFA in oncology.

Main Methods:

• Image-guided local cancer treatment assumes local disease control can improve survival.
• Ablative techniques are being applied to various tumors, including liver, bone, lung, breast, and adrenal neoplasms.
• Refinements in ablation technology allow treatment of large tumor volumes via image-guided needle placement.

Main Results:

• Image-guided needle placement enables treatment of large tumor volumes through percutaneous, laparoscopic, or open surgical approaches.
• Local disease control achieved through ablation may lead to improved survival or enhanced operability.
• Despite widespread use, consensus indications for RFA in oncology remain ill-defined.

Conclusions:

• Rigorous scientific review, long-term follow-up, and randomized prospective trials are necessary.
• These studies will help establish clear guidelines for the application of RFA in cancer treatment.
• Defining the precise role of RFA in oncology is crucial for its effective integration into patient care.